Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 456

Similar articles for PubMed (Select 11606380)

1.

Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.

Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM.

Cancer Res. 2001 Oct 15;61(20):7456-63.

2.
3.
5.

Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.

Waffo-Téguo P, Hawthorne ME, Cuendet M, Mérillon JM, Kinghorn AD, Pezzuto JM, Mehta RG.

Nutr Cancer. 2001;40(2):173-9.

PMID:
11962253
6.
7.

Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.

Kisková T, Jendželovský R, Rentsen E, Maier-Salamon A, Kokošová N, Papčová Z, Mikeš J, Orendáš P, Bojková B, Kubatka P, Svoboda M, Kajo K, Fedoročko P, Jäger W, Ekmekcioglu C, Kassayová M, Thalhammer T.

Eur J Cancer Prev. 2014 Nov;23(6):506-13. doi: 10.1097/CEJ.0000000000000083. Erratum in: Eur J Cancer Prev. 2015 Mar;24(2):165.

PMID:
25254309
8.

TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

Yamamoto Y, Shibata J, Yonekura K, Sato K, Hashimoto A, Aoyagi Y, Wierzba K, Yano S, Asao T, Buzdar AU, Terada T.

Clin Cancer Res. 2005 Jan 1;11(1):315-22.

9.

A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.

Kisková T, Ekmekcioglu C, Garajová M, Orendáš P, Bojková B, Bobrov N, Jäger W, Kassayová M, Thalhammer T.

Eur J Cancer Prev. 2012 Mar;21(2):163-70. doi: 10.1097/CEJ.0b013e32834c9c0f.

PMID:
22044852
10.

Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.

Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, Hilakivi-Clarke L.

Carcinogenesis. 2004 May;25(5):741-8. Epub 2004 Jan 16.

11.

Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.

Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S.

Biochem Pharmacol. 1995 Oct 26;50(9):1485-93.

PMID:
7503800
12.

A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.

Mehta RG, Williamson E, Patel MK, Koeffler HP.

J Natl Cancer Inst. 2000 Mar 1;92(5):418-23.

13.

Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.

Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG.

Carcinogenesis. 2004 Feb;25(2):211-8. Epub 2003 Oct 24.

14.

Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.

Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK.

Carcinogenesis. 2014 Aug;35(8):1872-80. doi: 10.1093/carcin/bgu120. Epub 2014 Jun 3.

15.

Estrogenic activity in white and red wine extracts.

Klinge CM, Risinger KE, Watts MB, Beck V, Eder R, Jungbauer A.

J Agric Food Chem. 2003 Mar 26;51(7):1850-7.

PMID:
12643641
16.

Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats.

McDougal A, Gupta MS, Morrow D, Ramamoorthy K, Lee JE, Safe SH.

Breast Cancer Res Treat. 2001 Mar;66(2):147-57.

PMID:
11437101
17.

Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.

Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.

Clin Cancer Res. 2002 Jun;8(6):1995-2001.

18.

Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.

Chisamore MJ, Ahmed Y, Bentrem DJ, Jordan VC, Tonetti DA.

Clin Cancer Res. 2001 Oct;7(10):3156-65.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk